The mechanism by which preconditioning (brief intermittent periods of ischemia and reflow) improves recovery of function and reduces enzyme release after a subsequent 30-minute period of ischemia was investigated in perfused rat hearts. Specifically, it was hypothesized that ischemia after preconditioning would result in a decreased production of H' and therefore a smaller rise in [Na+Ji and [Ca'+], via Na+-H+ and Na+-Ca2' exchange. To test this hypothesis we measured pHi, [Na+]i, [Ca'+]1, and cell high-energy phosphates during ischemia and reflow, and we correlated this with recovery of contractile function and release of creatine kinase during reflow. 31P nuclear magnetic resonance (NMR) was used to measure pH; and cell phosphates.
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The mechanism by which preconditioning (brief intermittent periods of ischemia and reflow) improves recovery of function and reduces enzyme release after a subsequent 30-minute period of ischemia was investigated in perfused rat hearts. Specifically, it was hypothesized that ischemia after preconditioning would result in a decreased production of H' and therefore a smaller rise in [Na+Ji and [Ca'+], via Na+-H+ and Na+-Ca2' exchange. To test this hypothesis we measured pHi, [Na+] i, [Ca'+]1, and cell high-energy phosphates during ischemia and reflow, and we correlated this with recovery of contractile function and release of creatine kinase during reflow. 31P nuclear magnetic resonance (NMR) was used to measure pH; and cell phosphates.
[Na+]i was measured by 'Na NMR using the shift reagent thulium 1,4,7,10 -tetraazacyclododecane-N,N, 'N",N"'-tetramethylenephosphonate to distinguish intracellular from extracellular sodium. [Ca2+1 was measured by`9F NMR using hearts loaded with 1,2-bis(2-amino-5-fluorophenoxy)ethane-N,N,N',N'-tetraacetic acid, termed 5F-BAPTA. Basal time-averaged levels of pHi,
[Na+];, and [Ca2"], were 7.07±0.08, 9.4±0.8 mM, and 715±31 nM, respectively. After 30 minutes of ischemia, in preconditioned hearts, pH. was 6.5+0.06, [Na+] i was 20.9+4.4 mM, [Ca2"]i was 2.1+0.4 ,uM, and ATP was negligible. In untreated hearts, after 30 minutes of ischemia, pH. was 6.3+0.08, [Na+l. was 26 .7±3.8 mM, [Ca 21]1 was 3.2±0.6 ,uM, and ATP was undetectable. During reperfusion after 30 minutes of ischemia, preconditioned hearts had significantly better recovery of contractile function than untreated hearts (71±9%o versus 36±o8% initial left ventricular developed pressure), and after 60 minutes of ischemia, preconditioned hearts had significantly less release of the intracellular enzyme creatine kinase (102± 12 versus 164±17 IU/g dry wt). We also found that unpreconditioned hearts arrested with 16 mM MgCI2 (to inhibit calcium entry via calcium channels and Na+-Ca2' exchange) before 30 minutes of ischemia recover function on reflow to the same extent as preconditioned hearts with or without magnesium arrest. Thus, preconditioning has no additional benefit in addition to magnesium arrest. In addition, in hearts that received 16 mM MgCl2 just before the 30-minute period of ischemia, preconditioning had no effect on the rise in [Ca2+Ji during the 30-minute period of ischemia. These data support the hypothesis that preconditioning attenuates the increase in [Ca2']I, [Na] ji, and [H']j during ischemia, most likely because of reduced stimulation of Na+-H+ and Na+-Ca'+ exchange. The data suggest that interventions that minimize ionic derangements during ischemia are associated with improved recovery of contractility and less enzyme release on reflow. (Circulation Research 1993; 72:112-125) KEY WoRDs * myocardial ischemia * preconditioning * nuclear magnetic resonance * cytosolic free calcium concentration * intracellular sodium concentration An understanding of the mechanisms involved in the transition from reversible to irreversible cell injury has been pursued for many years. Recently, it has been shown that several brief ischemic periods separated by brief periods of reflow (preconditioning) actually reduce necrosis after a subsequent longer (30-60-minute) period of ischemia.1-5 The mechanism by which preconditioning delays the transition from reversible to irreversible injury has been the subject of considerable interest, and several theories have been proposed. Thornton et Indeed, the adenosine effect could be mediated by inhibiting endogenous catecholamine release17 or attenuating the effects of f3-agonists and the rise in cAMP'8'19; however, 8-blockers do not appear to reduce infarct size as a percentage of the area at risk. 20 In this study, we have examined the effects of preconditioning on ionic alterations during ischemia. Knowledge of ionic alterations during preconditioning and subsequent ischemia is important in defining the mechanisms responsible for preconditioning. Since preconditioning has not been reproduced in isolated cells, it is a phenomenon that must be studied in intact animals or perfused organs. Preconditioning is protective in the isolated perfused heart as well as in vivo, as shown in a recent study21 that found that the reduction in infarct size due to preconditioning was the same in the in situ heart and the isolated heart. The [Ca 2+]i measurements are not presently feasible in intact animals. Therefore, we performed these studies on isolated perfused hearts. lip nuclear magnetic resonance (NMR) provides a noninvasive means of continuously measuring pH, and high-energy phosphates.
[Na+]i can be suitably monitored using '3Na NMR with infusion of shift reagents to distinguish intracellular from extracellular sodium. [22] [23] [24] [25] [Ca"2]j has been measured using 1,2-bis(2-amino-5-fluorophenoxy)ethane-N,N,N',N'-tetraacetic acid (5F-BAPTA)-loaded hearts and`9F NMR. [26] [27] [28] In spite of the reduced contractility in 5F-BAPTA-loaded hearts, this has been a fruitful method for measuring [ After loading with 5F-BAPTA, hearts were perfused with phosphate-free Krebs-Henseleit buffer (pH adjusted to 7.4 by adding HCl) for approximately 30 minutes, during which time the magnet was shimmed and several preischemic spectra were acquired. Phosphate-free buffer allows us to unambiguously assign the inorganic phosphate peak to the intracellular space as required for measuring pHi. The heart was placed in a standard 20-mm NMR tube with the apex of the heart approximately 1 cm from the bottom of the tube. The perfusate was evacuated by a variable speed Masterflex peristaltic pump connected to polyethylene tubing that extended to the bottom of the tube; thus, the heart was not bathed in perfusate.
For most experiments, the hearts were divided into two experimental groups. Both groups received 30 minutes of global ischemia; however, one group was pretreated with four periods of 5 minutes of ischemia each separated by 5 minutes of reflow (preconditioning). After the 30-minute ischemic period, both groups were reperfused with phosphate-free Krebs-Henseleit buffer. In each experimental group, some hearts were evaluated by`9F NMR, some were evaluated by lip NMR, and some were evaluated by 23Na NMR. Measurements of contractility were made in all experiments. In the no-treatment group, four hearts were studied by 19F NMR, four hearts were studied by lip NMR, and six hearts were studied by 23Na NMR. In the preconditioned group, eight hearts were studied by`9F NMR, seven hearts were studied by lIp NMR, and four hearts were studied by 23Na NMR. In one set of experiments, hearts were arrested by addition of 16 For assessment of contractile function, a latex balloon on the tip of a polyethylene catheter was inserted through the left atrium into the left ventricle. The catheter was connected to a Statham P23d pressure transducer that was outside the magnet at the same height as the heart. The balloon was inflated to give an end-diastolic pressure of 5-10 cm water. Initially, all hearts developed at least 100 cm H2O peak systolic pressure at an end-diastolic pressure of 10 cm H20 or less. 5F-BAPTA loading has been previously shown to buffer calcium transients and thereby decrease peak systolic pressure to approximately 25 cm H20 at an end-diastolic pressure of 10 cm H20.20 After loading with 5F-BAPTA, hearts were paced at 5 Hz using silver wire and an agar salt bridge connected to a stimulator (Grass Instrument Co., Quincy, Mass.).
These studies were performed on a wide-bore NMR spectrometer (model NT 9F NMR studies were carried out on the homogenate, to which a known concentration of 6-fluorotryptophan was added. The resonance intensity of 5F-BAPTA was then compared with that of the 6-fluorotryptophan, taking into account the differences in T1 and the number of fluorine nuclei. pHi was measured from the shift between intracellular inorganic phosphate and creatine phosphate, as described previously by Jacobus et al. 38 ATP, expressed as percent control, was determined by measuring the area under the 13-phosphate resonance of ATP. In the 23Na spectra, intracellular sodium was distinguished from extracellular sodium by using an extracellular shift reagent, thulium 1,4,7,10-tetraazacyclododecane-N,N',N' ',N" '-tetramethylenephosphonate (DOTP), which was synthesized as described by Sherry and 
where A(Na,) is the area under the resonance corresponding to intracellular sodium, Vi is the intracellular volume, fi is a correction reflecting the NMR visibility of the intracellular sodium resonance, and A(Na0), VO, and f0 are the corresponding parameters for extracellular sodium. With radioactive sorbitol used as an extracellular marker in saline-perfused rat hearts, the ratio VO/Vi was determined to be in the range of 0.9-1.4.41,42
In our calculations, we used a value of 1.0 for control perfusion conditions, and [Na+1, was 145 mM. There is some controversy regarding the degree of NMR visibility of intracellular sodium. In a study of this parameter, Springer43 reported that intracellular sodium is 40% visible. In our studies, we have set ft=0.4 and f0= 1.0 and made the assumption that the visibility of the 23Na resonance remains constant during the experiment. Creatine kinase (CK) release was measured by collecting the effluent and measuring CK activity spectrophotometrically. 44 Values are expressed as mean+SEM. The timematched data curves during ischemia were evaluated using analysis of variance for repeated measures. When F values indicated that significant differences were present, we then used Tukey's honestly significant difference method, which adjusts for multiple comparisons, to compare samples for statistical significance. Values ofp<0.05 were considered significant. Statistical evaluations were performed using SYSTAT software (SYSTAT Inc., Evanston, Ill.).
Results
Brief intermittent periods of myocardial ischemia (preconditioning) have been shown to provide protection against various manifestations of cell injury produced by a subsequent longer period of ischemia. In intact dogs,1,2 pigs,3 and rabbits,5 preconditioning has been shown to significantly decrease the area of necrosis produced by 30-60 minutes of ischemia. In a recent Figure 1A ) and decreases the release of the intracellular enzyme CK ( Figure 1B Figure 2 for an untreated heart ( Figure 2A ) and a heart preconditioned with intermittent periods of ischemia Typical '9F nuclear magnetic resonance spectra of an untreated (panel A) and preconditioned (panel B) SF-BAPTA-loaded rat heart before and at the end of30 minutes ofglobal ischemia. Spectra are averages of 1,500 accumulations (total acquisition time is 5 minutes) and are not gated to the cardiac cycle.
(preconditioned, Figure 2B ). As preconditioned hearts. In the untreated heart shown in Figure 2A , there was a large increase in the ratio of Ca2'-5F-BAPTA to uncomplexed 5F-BAPTA after 25-30 minutes of global total ischemia. In contrast, in the preconditioned heart ( Figure 2B ), by 25-30 minutes of total ischemia there is still a large uncomplexed 5F-BAPTA resonance, indicating a substantial difference from the untreated ischemic heart. The 31P NMR experiments were performed on hearts loaded with 5F-BAPTA. Figure 3 shows a series of 31p NMR spectra before and during global ischemia (25-30 minutes) in an untreated heart ( Figure 3A ) and a preconditioned heart ( Figure 3B) Figure 3 shows that, in both an untreated heart and a preconditioned heart, 30 minutes of ischemia results in a large increase in inorganic phosphate and a decrease in creatine phosphate and ATP to undetectable levels (<1.25 mM). Figure 3 also shows that the inorganic phosphate peak is shifted upfield (toward creatine phosphate) by 25-30 minutes of ischemia, consistent with a decrease in pH,. In the ischemic spectra, the upfield shift of the inorganic phosphate peak is greater in the untreated heart than in the preconditioned heart, indicating a more acidic pHi in the untreated heart than in the preconditioned heart.
The 23Na experiments were also performed on hearts loaded with SF-BAPTA and followed the same protocol, except that to distinguish intracellular sodium from extracellular sodium, 5 In contrast to the results for creatine phosphate, the ATP level at the end of the preconditioning period is significantly (p<0.05) below the preischemic value; as shown in Figure 5B, Time (min) FIGURE 9. Figure 9 ). Since injury develops much slower in a heart that has been arrested before ischemia, the possibility exists that the lack of difference is due to the time chosen. Thus, in an arrested heart, it may take a longer time for the protective effect of preconditioning to become significant. To evaluate this possibility, we examined 45-and 60-minute periods of ischemia and found preconditioning to have no effect on [Ca2"]i or recovery of function (data not shown). Our studies of adult rat myocardium show that there is a correlation between the magnitude of the ionic derangements during ischemia and the degree of stunning during reperfusion and between the magnitude of the ionic derangements during ischemia and the amount of enzyme release and that preconditioning can attenuate the ionic derangements, stunning, and enzyme release. We were interested in determining whether similar results would be observed in other species. We chose to study the guinea pig heart and found that, in contrast to the rat heart, preconditioning had no effect on recovery of contractile function after a 20-minute period of ischemia. Similarly, in guinea pigs, precondi- tioning did not affect the rise in [Ca2+]i during the prolonged period of ischemia (see Figure 10) . Thus, not all species show the same response to preconditioning. The Marban and coworkers37 showed that mitochondria isolated from 5F-BAPTA-loaded perfused hearts did not contain 5F-BAPTA. Furthermore, there is no indication that measurable 5F-BAPTA accumulates in endothelial cells or smooth muscle cells. Addition of bradykinin has been shown to increase [Ca2]1 in endothelium and smooth muscle cells but not in myocytes.31 It has been shown that addition of bradykinin to 5F-BAPTA-loaded perfused heart does not cause any measurable change in the 19F NMR spectra, indicating that the 5F-BAPTA resides primarily in the myocytes.37 If ischemia develops to the point at which the cell membrane becomes leaky, thereby allowing the indicator to leak from the cell, this method (and all other methods that rely on an intracellular indicator, such as aequorin and indo-1) is no longer valid. Therefore, we have been careful to limit our calcium measurements to short periods of ischemia, lular contents. In all cases, we have documented that during the time of the measurements there is no significant enzyme release and no significant leakage of 5F-BAPTA; we only include experiments in which there is no measurable loss of 5F-BAPTA from the heart on reflow. Thus, to correlate ion changes with enzyme release, we measure enzyme release after periods of ischemia that are longer than the duration of ischemia used in experiments for measurement of [Ca2"]1. In the experiments in which we measured CK release, the hearts were ischemic for 60 minutes; in contrast, in the experiments in which we measured [Ca2+]i, ischemic periods did not exceed 30 minutes.
[Na+Ji. 23Na, the naturally occurring sodium isotope, is readily measured using NMR; however, intracellular sodium has the same chemical shift as extracellular sodium. Addition of an extracellular shift reagent allows separation of intracellular from extracellular sodium. 43 This method requires that the shift reagent be stable and remain extracellular. Previous studies22'2339 '40 have shown that thulium DOTP meets these requirements. As is the case with 5F-BAPTA, if the plasma membrane becomes damaged, the shift reagent could enter the cell.
Thus, we have limited our measurements of [Na+]i to short periods of ischemia, during which there is no plasma membrane damage, as shown by the lack of enzyme release and the lack of 5F-BAPTA release.
CK release. In the perfused-heart model, CK release during reperfusion has often been used as a measure of lethal myocyte injury. CK release has been shown to correlate with the morphological assessment of the proportion of lethally injured myocytes as long as the left ventricle is maintained in a distended state throughout ischemia by inflating an intraventricular balloon that is deflated before reflow. [53] [54] [55] This was done in the present experiments. Previous work has shown that there is minimal CK release during aerobic perfusion,54 and we collected coronary effluent before the onset of ischemia to confirm that there was no detectable CK release under control conditions. During reflow after the ischemic period, the coronary effluent was collected for 20 minutes to estimate the amount of lethal myocyte injury. Previous work has shown that peak CK release occurs within the first 5 minutes of reflow.53-55 Although CK release is not complete after 20 minutes of reflow, this duration of reflow has been used previously, and a good correlation has been found between the amount of CK released and the morphological determination of the proportion of lethally damaged myocytes. Measurement of CK release is not equivalent to measurement of infarct size in in vivo models of ischemia, which requires 48-72 hours of reperfusion, but CK release provides a qualitative assessment of the amount of contraction band necrosis present during early reflow after a period of ischemia. [Ca>], increases before lethal ischemic or anoxic myocyte injury. Interventions that delay the rise in [Ca>] , correspondingly delay the onset of myocyte necrosis.14, 58 We have shown that addition of the calcium channel blocker diltiazem and cardioplegic arrest, which have been shown by others to delay the onset of irreversible injury, correspondingly delay the rise in [Ca2+],.14 Reducing extracellular calcium, which has also been shown to delay cell injury, has also been shown to slow the rise in [Ca>]j, both in the perfused heart model59 and in metabolically inhibited cultured heart cells.58 Thus, a strong correlation between an elevated [Ca >]i and cell injury has been shown. Therefore, we were interested in investigating whether preconditioning, which has been shown to delay the onset of cell injury, also delays the rise in [Ca2"]i. As shown in Figures 2 and 6 [Ca'2] i during the sustained period of ischemia has only been demonstrated in rats, and it is uncertain whether this relation will hold in other species. We attempted to confirm guinea pig heart, and we found that preconditioning did not cause an improvement in recovery of function on reflow after the sustained period of ischemia. There are no reports of preconditioning reducing necrosis in guinea pig hearts. Interestingly, the Na+-H+ exchange inhibitor amiloride, which blocks approximately 50% of the sodium uptake during ischemia in the rat heart, has no effect on sodium uptake in the guinea pig heart; this is attributed to a less active Na+-H+ exchanger in the guinea pig heart.67 If our hypothesis that preconditioning leads to less generation of H' and therefore less Na+-H+ exchange and less increase in [Ca2"], via Na+-Ca2`exchange is correct and if the guinea pig heart has a relatively inactive Na+-H+ exchanger, then one might expect that preconditioning would have little effect on ionic derangements during ischemia in guinea pig myocardium. Furthermore, if Na+-H+ and Na4-Ca`4 exchange are important mechanisms in the rise in [Ca4]I during ischemia and if the guinea pig heart has less active Na+-H+ exchange, then one might expect that [Ca'4] , would rise more slowly in the guinea pig heart than in the rat heart; this observation is confirmed in Figure 10 . In agreement with these data, the study of Galinanes and Hearse68 reports that, although pretreatment with a cardioplegic solution containing high magnesium significantly improved recovery of cardiac function in the rat and most other animal species studied, cardioplegia did not improve recovery of function in guinea pig hearts. Thus, the guinea pig heart appears to be substantially different from the hearts of most other species. The differences between rat and guinea pig myocardium suggest that significant species variation may be present in the response to preconditioning.
Reduced Metabolic Demand
Although our data suggest that reduced Na+-H+ and Na4-Ca`4 exchange due to decreased H' production can explain the ionic effects of preconditioning, another hypothesis that must be considered is that the attenuation of ionic changes in ischemic preconditioned hearts is primarily a function of greater high-energy phosphate availability. Previous studies14 have shown that there is a good correlation between the fall in tissue ATP and the rise in [Ca'4]i during ischemia under a variety of experimental conditions. However, the ATP levels in preconditioned and untreated hearts are very similar during most of the ischemic period; therefore, it is unlikely that a difference in ATP concentration is responsible for the improved ionic homeostasis. It has been suggested that glycolytically generated ATP is preferentially used to maintain ion pumps,69 but this is unlikely to be a factor in preconditioning, since preconditioned hearts generate less lactate than untreated hearts.' However, it is possible that it is not total tissue ATP but ATP in some specific compartment that is important and that preconditioning preferentially preserves this ATP pool. Although there is no experimental evidence that improved ATP availability is a factor in the attenuation of ionic derangements in ischemic preconditioned hearts, there is good evidence that metabolic demand is reduced in ischemic preconditioned myocardium.1 One manifestation of the reduced metabolic demand is that the rate of decline in tissue ATP content during the whether this correlation would be observed in the tioned heart (see Figure 5 and Reference 1). Furthermore, the rate of decline in tissue ATP content underestimates the actual decrease in metabolic demand because 1) ATP consumption is the sum of ATP produced by anaerobic glycolysis and ATP lost from tissue reserves, and 2) glycolytic ATP production during ischemia is less in preconditioned than in untreated hearts, as estimated by lactate accumulation. Thus, the data indicate that preconditioning both reduces ATP consumption and minimizes early ionic derangements.
Since [Ca"2]i appears to be an independent regulator of ATP consumption during metabolic inhibition58 and ischemia,14 the reduced rate of ATP consumption may be related, at least in part, to a decrease in Na+-H+ and Na+-Ca2' exchange. However, this does not exclude the possibility that other factors are involved as well. Other factors could include adenosine or some other mediator that is produced during the preconditioning period and is not immediately washed out during the final reflow period.67 Adenosine has been shown to activate a potassium channel,7071 which decreases action potential duration; this could be expected to decrease ATP utilization.
In summary, the present study generally supports the conclusions of our previous studies14'23 that cardioprotective interventions instituted before a sustained period of ischemia delay but do not prevent the rise in [Ca2"Ii during ischemia and delay but do not prevent lethal myocyte injury. The cardioprotective effects of preconditioning are likely multifactorial and may involve both reduction in metabolic demand and attenuation of ionic derangements. The data are consistent with the hypothesis that increased [Ca2+] is an important pathogenetic factor in the development of stunning and plasma membrane disruption and that one of the beneficial effects of preconditioning is the decrease in anaerobic glycolysis, resulting in less acidosis, less Na+-H+ exchange, and less Na+-Ca2' exchange than in untreated hearts.
